Danaher | DHR - Interest Expense On Debt


Danaher reported $135M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Agilent USD 29M 4M Jun/2026
Align Technology USD 6.93M 9.11M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Bio Techne USD 3.6M 1.19M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Danaher USD 135M 28M Sep/2026
Dentsply International USD 22M 2M Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
ESCO Technologies USD 8.71M 6.31M Jun/2026
Fortive USD 35.4M 3.8M Jun/2026
Henry Schein USD 43M 4M Jun/2026
Illumina USD 24M 2M Mar/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
IQVIA Holdings USD 197M 5M Jun/2026
Keysight Technologies USD 26M 1000K Jun/2026
Laboratory Of America USD 61.1M 6M Jun/2026
Medtronic USD 186M 10M Jun/2026
Mettler Toledo International USD 17.25M 239K Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quest Diagnostics USD 61M 8M Sep/2026
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.66M 85K Jun/2026
Revvity USD 22.99M 1.73M Jun/2026
Roper Industries USD 93.3M 3.6M Dec/2025
Stryker USD 47.93B 1.64B Jun/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
Waters USD 55M 13M Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026